The roles of MCP-1 and protein kinase Cδ activation in human eosinophilic leukemia EoL-1 cells

Cytokine

Volumn 48, Issue 3, 2009, Pages 186-195

  Lee, Ji Sook ^a,b   Yang, Eun Ju ^a   Kim, In Sik ^a  

^a Eulji University   (South Korea)

^b Daejeon University   (South Korea)

Author keywords

Apoptosis; Cell migration; EoL 1 cells; MCP 1; PKC

Indexed keywords

(14.7K INTERACTING PROTEIN 1) LIKE 1 PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA; CASPASE 3; CASPASE 9; CHEMOKINE RECEPTOR CCR2; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE C; PROTEIN KINASE C DELTA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EOSINOPHIL; EOSINOPHILIA; EOSINOPHILIC LEUKEMIA; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CHEMOKINE CCL2; ENZYME ACTIVATION; EOSINOPHILS; FLOW CYTOMETRY; HUMANS; HYPEREOSINOPHILIC SYNDROME; NF-KAPPA B; PROTEIN KINASE C-DELTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 70350014883     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.07.008     Document Type: Article

References (33)

1. Gotlib J., Cools J., Malone III J.M., Schrier S.L., Gilliland D.G., and Coutré S.E. The FIP1L1-PDGFR alpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 103 (2004) 2879-2891
2. Tefferi A., Patnaik M.M., and Pardanani A. Eosinophilia: secondary, clonal and idiopathic. Br J Haematol 133 (2006) 468-492
3. Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D., Cortes J., et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348 (2003) 1201-1214
4. Ishihara K., Kitamura H., Hiraizumi K., Kaneko M., Takahashi A., Zee O., et al. Mechanisms for the proliferation of eosinophilic leukemia cells by FIP1L1-PDGFRalpha. Biochem Biophys Res Commun 366 (2008) 1007-1011
5. Pan J., Quintás-Cardama A., Manshouri T., Giles F.J., Lamb P., Tefferi A., et al. The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1. Leukemia 21 (2007) 1395-1404
6. Verstovsek S., Giles F.J., Quintás-Cardama A., Manshouri T., Huynh L., Manley P., et al. Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells. Leuk Res 30 (2006) 1499-1505
7. Murdoch C., and Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95 (2000) 3032-3043
8. Broxmeyer H.E. Regulation of hematopoiesis by chemokine family members. Int J Hematol 74 (2001) 9-17
9. Gerard C., and Rollins B.J. Chemokines and disease. Nat Immunol 2 (2001) 108-115
10. Murphy P.M., Baggiolini M., Charo I.F., Hébert C.A., Horuk R., Matsushima K., et al. International union of pharmacology XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52 (2000) 145-176
11. o protein/PLC/PKC delta/Ras cascades in HOS cells. Life Sci 73 (2003) 447-459
12. Okhrimenko H., Lu W., Xiang C., Ju D., Blumberg P.M., Gomel R., et al. Roles of tyrosine phosphorylation and cleavage of protein kinase C delta in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis. J Biol Chem 280 (2005) 23643-23652
13. Ko J., Kim I.S., Jang S.W., Lee Y.H., Shin S.Y., Min do S., et al. Leukotactin-1/CCL15-induced chemotaxis signaling through CCR1 in HOS cells. FEBS Lett 515 (2002) 159-164
14. Wang Q.J., Acs P., Goodnight J., Giese T., Blumberg P.M., Mischak H., et al. The catalytic domain of protein kinase C-delta in reciprocal delta and epsilon chimeras mediates phorbol ester-induced macrophage differentiation of mouse promyelocytes. J Biol Chem 272 (1997) 76-82
15. Bankers-Fulbright J.L., Kita H., Gleich G.J., and O'Grady S.M. Regulation of human eosinophil NADPH oxidase activity: a central role for PKC delta. J Cell Physiol 189 (2001) 306-315
16. Lee J.S., Kim I.S., Ryu J.S., and Yun C.Y. House dust mite, Dermatophagoides pteronissinus increases expression of MCP-1, IL-6, and IL-8 in human monocytic THP-1 cells. Cytokine 42 (2008) 365-371
17. Ko J., Yun C.Y., Lee J.S., Kim D.H., Yuk J.E., and Kim I.S. Differential regulation of CC chemokine receptors by 9-cis retinoic acid in the human mast cell line, HMC-1. Life Sci 79 (2006) 1293-1300
18. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 18 (2000) 217-242
19. Dunzendorfer S., Kaneider N.C., Kaser A., Woell E., Frade J.M., Mellado M., et al. Functional expression of chemokine receptor 2 by normal human eosinophils. J Allergy Clin Immunol 108 (2001) 581-587
20. Sano M., Leff A.R., Myou S., Boetticher E., Meliton A.Y., Learoyd J., et al. Regulation of interleukin-5-induced beta2-integrin adhesion of human eosinophils by phosphoinositide 3-kinase. Am J Respir Cell Mol Biol 33 1 (2005) 65-70
21. Laurence A.D. Location, movement and survival: the role of chemokines in haematopoiesis and malignancy. Br J Haematol 132 (2006) 255-267
22. Griffin J.H., Leung J., Bruner R.J., Caligiuri M.A., and Briesewitz R. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci USA 100 (2003) 7830-7835
23. Cools J., Quentmeier H., Huntly B.J., Marynen P., Griffin J.D., Drexler H.G., et al. The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood 103 (2004) 2802-2805
24. Robert C., Delva L., Balitrand N., Nahajevszky S., Masszi T., Chomienne C., et al. Apoptosis induction by retinoids in eosinophilic leukemia cells: implication of retinoic acid receptor-alpha signaling in all-trans-retinoic acid hypersensitivity. Cancer Res 66 (2006) 6336-6344
25. Benekli M., Xia Z., Donohue K.A., Ford L.A., Pixley L.A., Baer M.R., et al. Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival. Blood 99 (2002) 252-257
26. Spiekermann K., Bagrintseva K., Schwab R., Schmieja K., and Hiddemann W. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells. Clin Cancer Res 9 (2003) 2140-2150
27. Ringshausen I., Dechow T., Schneller F., Weick K., Oelsner M., Peschel C., et al. Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells. Leukemia 18 (2004) 1964-1970
28. Ringshausen I., Schneller F., Bogner C., Hipp S., Duyster J., Peschel C., et al. Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase C delta. Blood 100 (2002) 3741-3748
29. Ringshausen I., Oelsner M., Weick K., Bogner C., Peschel C., and Decker T. Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL. Leukemia 20 (2006) 514-520
30. Yang J., Ikezoe T., Nishioka C., Tasaka T., Taniguchi A., Kuwayama Y., et al. AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. Blood 110 (2007) 2034-2040
31. Lierman E., Folens C., Stover E.H., Mentens N., Van Miegroet H., Scheers W., et al. Sorafenib is a potent inhibitor of FIP1L1-PDGFR alpha and the imatinib-resistant FIP1L1-PDGFR alpha T674I mutant. Blood 108 (2006) 1374-1376
32. Khwaja A., and Tatton L. Caspase-mediated proteolysis and activation of protein kinase C delta plays a central role in neutrophil apoptosis. Blood 94 (1999) 291-301
33. Yamaguchi T., Suzuki M., Kimura H., and Kato M. Role of protein kinase C in eosinophil function. Allergol Int 55 (2006) 245-252